Sign In
Buy OCX
$3.20
+0 (+0%)
At Close: Sep 16, 2025
Oncocyte Changes Name to Insight Molecular Diagnostics Inc. (iMDx), Moves Headquarters to Nashville
07:00am, Tuesday, 17'th Jun 2025
New name aligns with mission to deliver precision biomarker-based testing for both transplant and oncology care iMDx sponsoring GraftAssureIQ™ research-use-only kits at transplant labs globally Exhi
Medicare Boosts Reimbursement for Oncocyte's Flagship Technology
04:05pm, Monday, 19'th May 2025
IRVINE, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp., (Nasdaq: OCX), a diagnostics technology company, today provided a positive update on pricing for its next-generation lab-developed test
OncoCyte Corporation (OCX) Q1 2025 Earnings Call Transcript
11:32pm, Monday, 12'th May 2025
OncoCyte Corporation (NASDAQ:OCX ) Q1 2025 Earnings Conference Call May 12, 2025 5:00 PM ET Company Participants Gabby Woody - Executive Assistant, HR Coordinator Josh Riggs - President & Chief Execut
Oncocyte Reports Q1 2025 Results and Business Progress
04:05pm, Monday, 12'th May 2025
IRVINE, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp. (Nasdaq: OCX), a diagnostics technology company, today published the following letter to shareholders in conjunction with its first quar
Oncocyte to Release First Quarter 2025 Results on May 12, 2025
04:10pm, Wednesday, 07'th May 2025
IRVINE, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp., (Nasdaq: OCX), a leading diagnostics technology company, today announced that it will report first quarter 2025 financial results after
Oncocyte to Release First Quarter 2025 Results on May 12, 2025
04:08pm, Wednesday, 07'th May 2025
IRVINE, Calif., May 7, 2025 – PRISM MediaWire – Oncocyte Corp., (Nasdaq: OCX), a leading diagnostics technology company, today announced that it will report first quarter 2025 financial results af
Best Momentum Stocks to Buy for May 6th
11:00am, Tuesday, 06'th May 2025
MAIA, BYRN and OCX made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 6, 2025.
New Strong Buy Stocks for May 6th
08:45am, Tuesday, 06'th May 2025
MAIA, BYRN, OCX, BBVA and HMY have been added to the Zacks Rank #1 (Strong Buy) List on May 6, 2025.
Oncocyte Provides Positive Update on Clinical Trial Progress
08:30am, Wednesday, 30'th Apr 2025
IRVINE, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp., (Nasdaq: OCX), a leading diagnostics technology company, today provided a positive update on its substantial progress toward initiati
Oncocyte's Proprietary Assay Demonstrates Long-Term Clinical Validity
08:30am, Tuesday, 29'th Apr 2025
Robust data set of 131 patients with 151 kidney biopsies enrolled over four years at Charité University in Berlin Supports market expansion for testing of high-risk patient population New findings ad
New Strong Buy Stocks for April 24th
07:35am, Thursday, 24'th Apr 2025
YARIY, OCX, SMHI, VTMX and BANF have been added to the Zacks Rank #1 (Strong Buy) List on April 24, 2025.
OncoCyte (OCX) Upgraded to Buy: What Does It Mean for the Stock?
01:00pm, Monday, 07'th Apr 2025
OncoCyte (OCX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Oncocyte to Participate in 24th Annual Needham Virtual Healthcare Conference
08:47am, Wednesday, 02'nd Apr 2025
IRVINE, Calif., April 2, 2025 – PRISM MediaWire – Oncocyte Corp. (Nasdaq: OCX), a leading diagnostics technology company, today announced that Chief Executive Officer Josh Riggs and Chief Financia
Oncocyte to Participate in 24th Annual Needham Virtual Healthcare Conference
08:45am, Wednesday, 02'nd Apr 2025
IRVINE, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp. (Nasdaq: OCX), a leading diagnostics technology company, today announced that Chief Executive Officer Josh Riggs and Chief Financial O
OncoCyte Corporation (OCX) Q4 2024 Earnings Call Transcript
06:53pm, Monday, 24'th Mar 2025
OncoCyte Corporation (NASDAQ:OCX ) Q4 2024 Earnings Conference Call March 24, 2025 5:00 PM ET Company Participants Gabby Woody - Executive Assistant, HR Coordinator Josh Riggs - President and CEO Andr
